Benzyl Alcohol Patent Expiration
Benzyl Alcohol is Used for treating lice infestations through topical application. It was first introduced by Shionogi Inc
Benzyl Alcohol Patents
Given below is the list of patents protecting Benzyl Alcohol, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ulesfia | US7294342 | Ectoparasite asphyxiator compositions and methods for their application |
May 19, 2024
(Expired) | Shionogi |
| Ulesfia | US6793931 | Ectoparasite asphyxiator compositions and methods for their applications |
Jul 11, 2022
(Expired) | Shionogi |
| Ulesfia | US5858383 | Methods and compositions for topical treatment of ectoparasites |
Aug 11, 2017
(Expired) | Shionogi |
| Ulesfia | US6139859 | Methods and compositions for topical treatment of ectoparasites |
Aug 11, 2017
(Expired) | Shionogi |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Benzyl Alcohol's patents.
Latest Legal Activities on Benzyl Alcohol's Patents
Given below is the list recent legal activities going on the following patents of Benzyl Alcohol.
| Activity | Date | Patent Number |
|---|---|---|
| ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 25 Jul, 2019 | US7294342(Litigated) |
| 11.5 yr surcharge- late pmt w/in 6 mo, Large Entity | 25 Jul, 2019 | US7294342(Litigated) |
| Maintenance Fee Reminder Mailed Critical
| 01 Jul, 2019 | US7294342(Litigated) |
| Mail-Petition Decision - Accept Late Payment of Maintenance Fees - Granted Critical
| 27 Oct, 2015 | US6793931 |
| Petition Decision - Accept Late Payment of Maintenance Fees - Granted Critical
| 26 Oct, 2015 | US6793931 |
| Petition to Accept Late Payment of Maintenance Fee Payment Filed Critical
| 16 Sep, 2015 | US6793931 |
| Email Notification Critical
| 14 Sep, 2015 | US6793931 |
| Mail O.P. Petition Decision | 14 Sep, 2015 | US6793931 |
| Electronic Review Critical
| 14 Sep, 2015 | US6793931 |
| Mail-Petition Decision - Accept Late Payment of Maintenance Fees - Dismissed | 10 Sep, 2015 | US6793931 |
Benzyl Alcohol's Family Patents
Explore Our Curated Drug Screens
Clinical Trials
Recent Clinical Trials on Benzyl Alcohol:
Sometimes companies keep conducting clinical trials even after the drug's approval to discover new formulations, methods of use, or new treatment indications, so they could file for additional patents or receive regulatory exclusivity extensions, such as pediatric exclusivity, potentially delaying generic competition. Based on these recent clinical trials, generic companies need to consider the potential for new intellectual property or regulatory hurdles. These strategic moves by the drug owner might delay generic substitution or lead to additional sales of the brand drug, even after patent expiry.
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
| ||||
| A Study of the Efficacy, Safety and Pharmacokinetics of RPH-051 and Perjeta® in Combination With Trastuzumab and Docetaxel as the 1st Line Therapy in Patients With HER2-positive Breast Cancer | R-Pharm | NA |
ACTIVE NOT RECRUITING
(Jul 1, 2026)
| PHASE3 |
| LUT017 Gel for Venous Leg Ulcers and Chronic Non-Healing Skin Wounds in Adults | Antoni Ribas | NA |
NOT YET RECRUITING
(May 1, 2026)
| PHASE1 |
| Study of LUT017 Gel to Improve Healing of Skin Wounds After Removal of Benign Lesions in Healthy Adults | Antoni Ribas | NA |
NOT YET RECRUITING
(May 1, 2026)
| PHASE1 |
| Clindamycin as an Alternative to Vancomycin in Patients Undergoing Aortic Cardiac Surgery With Extracorporeal Circulation (ECC) | Nantes University Hospital | NA |
RECRUITING
(Apr 1, 2026)
| PHASE2 |